Search - tctmd.com

Displaying 221 - 240 of 325

Sort: Relevancy | Date

News Conference News ESC 2021

In HFrEF, AI Shows Promise For Predicting Beta Blocker Response

Yael L. Maxwell

September 03, 2021

News Conference News ESC 2021

AV Junction Ablation Plus CRT Cuts Deaths in Permanent AF Subset

Todd Neale

September 01, 2021

News Conference News ESC 2021

EMPEROR-Preserved: Empagliflozin Improves Outcomes in HFpEF

Todd Neale

August 27, 2021

News Daily News

Retracted Over Fraud Concerns, Surgisphere ACE/ARB Study Still Gets Cited

Michael O'Riordan

August 03, 2021

News Daily News

Hospital Stays for Meth-Related HF Skyrocket, as Do Costs

Caitlin E. Cox

July 14, 2021

News Daily News

Making the Case for Sex-Specific CVD Guidelines

L.A. McKeown

July 08, 2021

News Daily News

Closing the Gender Gap in Cardiology Clinical Trial Leadership: A Road Map

Shelley Wood

June 11, 2021

News Conference News ACC 2021

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Michael O'Riordan

May 25, 2021

News Conference News ACC 2021

Omecamtiv Mecarbil Has Biggest Benefit at Lowest EFs

Todd Neale

May 18, 2021

News Conference News ACC 2021

REHAB-HF: Tailored Cardiac Rehab Promotes Physical Function After Hospital Stay

Caitlin E. Cox

May 16, 2021

News Conference News ACC 2021

PARADISE-MI: ARNI Doesn’t Surpass ACE Inhibitor After Acute MI

L.A. McKeown

May 15, 2021

News Daily News

Women Treated for Acute HF Report Worse QoL Than Men

Caitlin E. Cox

March 12, 2021

News Opinion CV Team Dispatch

March 2021 News Roundup

L.A. McKeown

March 01, 2021

News Daily News

Women’s Risk for CVD Seen at Lower BP Thresholds Than Men

L.A. McKeown

February 24, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2021

Shelley Wood

February 03, 2021

News Opinion CV Team Dispatch

February 2021 News Roundup

L.A. McKeown

February 01, 2021

News Daily News

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Michael O'Riordan

January 28, 2021

News Daily News

Hospitalization for HF After Acute MI More Common in Women Than Men

L.A. McKeown

January 15, 2021

News Daily News

More Women Than Men Develop HF or Die After STEMI

L.A. McKeown

December 01, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2020

Shelley Wood

November 30, 2020

Advertisement

In HFrEF, AI Shows Promise For Predicting Beta Blocker Response

AV Junction Ablation Plus CRT Cuts Deaths in Permanent AF Subset

EMPEROR-Preserved: Empagliflozin Improves Outcomes in HFpEF

Retracted Over Fraud Concerns, Surgisphere ACE/ARB Study Still Gets Cited

Hospital Stays for Meth-Related HF Skyrocket, as Do Costs

Making the Case for Sex-Specific CVD Guidelines

Closing the Gender Gap in Cardiology Clinical Trial Leadership: A Road Map

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Omecamtiv Mecarbil Has Biggest Benefit at Lowest EFs

REHAB-HF: Tailored Cardiac Rehab Promotes Physical Function After Hospital Stay

PARADISE-MI: ARNI Doesn’t Surpass ACE Inhibitor After Acute MI

Women Treated for Acute HF Report Worse QoL Than Men

March 2021 News Roundup

Women’s Risk for CVD Seen at Lower BP Thresholds Than Men

TCTMD’s Top 10 Most Popular Stories for January 2021

February 2021 News Roundup

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Hospitalization for HF After Acute MI More Common in Women Than Men

More Women Than Men Develop HF or Die After STEMI

TCTMD’s Top 10 Most Popular Stories for November 2020

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content